Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude | 13 | 2024 | 473 | 1.940 |
Why?
|
| Sports | 5 | 2023 | 211 | 1.330 |
Why?
|
| Acclimatization | 9 | 2024 | 172 | 1.210 |
Why?
|
| Oxygen Consumption | 7 | 2024 | 724 | 0.820 |
Why?
|
| Physical Conditioning, Human | 2 | 2013 | 39 | 0.790 |
Why?
|
| Athletic Performance | 3 | 2024 | 76 | 0.790 |
Why?
|
| Physical Fitness | 4 | 2007 | 209 | 0.760 |
Why?
|
| Physical Endurance | 7 | 2024 | 278 | 0.760 |
Why?
|
| Hypoxia | 7 | 2024 | 1199 | 0.750 |
Why?
|
| Awards and Prizes | 1 | 2023 | 70 | 0.730 |
Why?
|
| Residence Characteristics | 2 | 2013 | 377 | 0.640 |
Why?
|
| Physical Education and Training | 4 | 2007 | 71 | 0.580 |
Why?
|
| Erythropoiesis | 5 | 2013 | 57 | 0.460 |
Why?
|
| Running | 4 | 2012 | 228 | 0.450 |
Why?
|
| Oxygen | 5 | 2013 | 995 | 0.350 |
Why?
|
| Hemoglobins | 4 | 2024 | 384 | 0.320 |
Why?
|
| Muscle Contraction | 1 | 2012 | 429 | 0.300 |
Why?
|
| Athletes | 2 | 2024 | 419 | 0.260 |
Why?
|
| Erythropoietin | 3 | 2007 | 100 | 0.240 |
Why?
|
| Bicycling | 2 | 2004 | 120 | 0.230 |
Why?
|
| Inhalation | 1 | 2004 | 29 | 0.220 |
Why?
|
| Doping in Sports | 1 | 2002 | 5 | 0.180 |
Why?
|
| Hematinics | 1 | 2002 | 22 | 0.180 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 1795 | 0.180 |
Why?
|
| Task Performance and Analysis | 3 | 2007 | 198 | 0.150 |
Why?
|
| Nitrogen | 2 | 2013 | 170 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2004 | 1339 | 0.130 |
Why?
|
| Altitude Sickness | 2 | 2010 | 141 | 0.130 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2017 | 62 | 0.130 |
Why?
|
| Exercise | 2 | 2024 | 2201 | 0.110 |
Why?
|
| Atmospheric Pressure | 1 | 2013 | 26 | 0.100 |
Why?
|
| Humans | 16 | 2024 | 144759 | 0.100 |
Why?
|
| Ethiopia | 1 | 2012 | 44 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2012 | 36 | 0.090 |
Why?
|
| Competitive Behavior | 1 | 2012 | 43 | 0.090 |
Why?
|
| Kenya | 1 | 2012 | 129 | 0.090 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 211 | 0.080 |
Why?
|
| Military Personnel | 2 | 2010 | 741 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 372 | 0.080 |
Why?
|
| Energy Metabolism | 2 | 2012 | 935 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 1326 | 0.070 |
Why?
|
| Motivation | 1 | 2012 | 610 | 0.060 |
Why?
|
| Genotype | 1 | 2012 | 1833 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 297 | 0.060 |
Why?
|
| Adult | 8 | 2024 | 40449 | 0.060 |
Why?
|
| Lipid Peroxides | 1 | 2004 | 10 | 0.050 |
Why?
|
| Malondialdehyde | 1 | 2004 | 30 | 0.050 |
Why?
|
| Diet | 1 | 2012 | 1273 | 0.050 |
Why?
|
| Posture | 1 | 2005 | 196 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2004 | 312 | 0.050 |
Why?
|
| Rest | 1 | 2024 | 124 | 0.050 |
Why?
|
| Phenotype | 1 | 2012 | 3162 | 0.050 |
Why?
|
| Oxyhemoglobins | 1 | 2003 | 28 | 0.050 |
Why?
|
| Glutathione | 1 | 2004 | 375 | 0.050 |
Why?
|
| Isoelectric Focusing | 1 | 2002 | 30 | 0.050 |
Why?
|
| Epoetin Alfa | 1 | 2002 | 9 | 0.050 |
Why?
|
| Electrophoresis | 1 | 2002 | 31 | 0.040 |
Why?
|
| Male | 8 | 2024 | 72315 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1370 | 0.030 |
Why?
|
| Hematocrit | 2 | 2010 | 108 | 0.030 |
Why?
|
| Reference Values | 2 | 2010 | 797 | 0.030 |
Why?
|
| Acute Disease | 2 | 2010 | 1030 | 0.030 |
Why?
|
| Iron | 1 | 2017 | 359 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 14105 | 0.020 |
Why?
|
| Female | 4 | 2024 | 78271 | 0.020 |
Why?
|
| Ferritins | 1 | 2010 | 69 | 0.020 |
Why?
|
| Mass Screening | 1 | 2017 | 1347 | 0.020 |
Why?
|
| Wyoming | 1 | 2007 | 27 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 427 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 310 | 0.010 |
Why?
|
| Reticulocyte Count | 1 | 2003 | 7 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2003 | 28 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1306 | 0.010 |
Why?
|
| Solubility | 1 | 2003 | 242 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2005 | 421 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2005 | 842 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 1985 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 2029 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 7990 | 0.010 |
Why?
|
| Colorado | 1 | 2007 | 4564 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 7173 | 0.010 |
Why?
|
| Biomarkers | 1 | 2003 | 4271 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 10779 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2007 | 17066 | 0.000 |
Why?
|